Everest Organics Surges 15.44%: 5 Key Factors Behind This Week’s Rally

6 hours ago
share
Share Via
Everest Organics Ltd delivered a robust weekly performance, surging 15.44% from Rs.458.25 to Rs.529.00 between 29 December 2025 and 2 January 2026, significantly outpacing the Sensex’s modest 1.35% gain over the same period. The stock hit multiple new 52-week and all-time highs during the week, reflecting strong momentum amid a mixed broader market environment. Key events including record intraday highs, technical strength, and upgraded ratings contributed to this notable rally.




Key Events This Week


29 Dec 2025: New 52-week and all-time high at Rs.503.9


30 Dec 2025: Record high of Rs.513.8 despite intraday volatility


2 Jan 2026: New 52-week and all-time high at Rs.536.4


Week Close: Rs.529.00 (+15.44%) vs Sensex +1.35%





Week Open
Rs.458.25

Week Close
Rs.529.00
+15.44%

Week High
Rs.536.4

Sensex Change
+1.35%



29 December 2025: New 52-Week and All-Time High at Rs.503.9


Everest Organics Ltd began the week on a strong note, surging 9.66% to close at Rs.502.50, marking a new 52-week and all-time high. The stock outperformed the Sensex, which declined 0.41% to 37,140.23. Intraday volatility was elevated, with prices ranging from Rs.442.05 to Rs.503.9, reflecting active trading and investor interest. The stock’s ability to trade above all key moving averages signalled sustained bullish momentum. This performance underscored Everest Organics’ leadership within the Pharmaceuticals & Biotechnology sector amid a cautious market backdrop.



30 December 2025: Record High of Rs.513.8 Amid Volatility


On 30 December, Everest Organics touched a fresh 52-week and all-time high of Rs.513.8, continuing its upward trajectory. However, the stock closed lower at Rs.489.30, down 2.63%, reflecting profit-taking and intraday volatility. Despite the decline, the stock maintained levels above all major moving averages, indicating a strong technical foundation. The broader Sensex was nearly flat, down 0.01%, at 37,135.83. The stock’s intraday low of Rs.488 highlighted some selling pressure, but the overall trend remained positive given the new high reached earlier in the session.




Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.



  • - Recent Top 1% qualifier

  • - Impressive market performance

  • - Sector leader


See What's Driving the Rally →




31 December 2025: Recovery with 3.37% Gain


Closing the year, Everest Organics rebounded strongly on 31 December, gaining 3.37% to close at Rs.505.80 on increased volume. This recovery coincided with a positive Sensex move of 0.83%, which closed at 37,443.41. The stock’s resilience after the previous day’s dip demonstrated sustained investor confidence and technical strength, supported by its position above key moving averages. The volume spike to 8,576 shares indicated renewed buying interest ahead of the new year.



1 January 2026: Minor Correction Amid Flat Market


On the first trading day of 2026, Everest Organics experienced a slight pullback, declining 1.15% to Rs.500.00 on relatively low volume. The Sensex edged up 0.14% to 37,497.10, reflecting a cautious market mood. Despite the minor correction, the stock remained well supported technically, maintaining its position above all major moving averages. This consolidation phase was typical following a strong rally, allowing the stock to digest gains.



2 January 2026: New 52-Week and All-Time High at Rs.536.4


Everest Organics capped the week with a powerful surge, hitting a new 52-week and all-time high of Rs.536.4. The stock closed at Rs.529.00, up 5.80% on the day, significantly outperforming the Sensex’s 0.81% gain. The intraday high represented a 7.28% jump from the previous close, signalling strong buying momentum. The stock’s ability to sustain trading above all key moving averages reinforced its robust technical position. This rally was supported by an upgraded Mojo Grade to ‘Hold’ and a Mojo Score of 57.0, reflecting improved fundamentals and market sentiment.




Is Everest Organics Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!



  • - Better alternatives suggested

  • - Cross-sector comparison

  • - Portfolio optimization tool


Find Better Alternatives →




Daily Price Comparison: Everest Organics Ltd vs Sensex


















































Date Stock Price Day Change Sensex Day Change
2025-12-29 Rs.502.50 +9.66% 37,140.23 -0.41%
2025-12-30 Rs.489.30 -2.63% 37,135.83 -0.01%
2025-12-31 Rs.505.80 +3.37% 37,443.41 +0.83%
2026-01-01 Rs.500.00 -1.15% 37,497.10 +0.14%
2026-01-02 Rs.529.00 +5.80% 37,799.57 +0.81%



Key Takeaways


Strong Momentum and Technical Strength: Everest Organics consistently traded above all major moving averages throughout the week, signalling sustained bullish momentum and technical resilience.


Multiple New Highs: The stock hit new 52-week and all-time highs on three separate occasions, reflecting robust investor confidence and price discovery at elevated levels.


Outperformance vs Sensex: The stock’s 15.44% weekly gain far exceeded the Sensex’s 1.35% rise, highlighting its leadership within the Pharmaceuticals & Biotechnology sector.


Volatility and Profit-Taking: Intraday volatility was notable, especially on 30 December when the stock closed lower despite a new high, indicating short-term profit-taking amid a strong uptrend.


Improved Market Sentiment: The upgrade in Mojo Grade from ‘Sell’ to ‘Hold’ and a Mojo Score of 57.0 reflect improved fundamentals and positive market perception.


Sectoral Context: Everest Organics’ outperformance amid a mixed sector and broader market environment underscores its competitive positioning and operational strength.



Conclusion


Everest Organics Ltd’s impressive 15.44% gain over the week ending 2 January 2026, marked by multiple new highs and strong technical indicators, demonstrates the stock’s robust momentum and resilience within the Pharmaceuticals & Biotechnology sector. Despite intermittent volatility and profit-taking, the stock maintained a clear uptrend, significantly outperforming the Sensex. The upgraded Mojo Grade and sustained trading above key moving averages further reinforce the positive outlook on the company’s market position. This week’s performance highlights Everest Organics as a notable growth story, reflecting both operational strength and investor confidence amid a cautious broader market.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News